CMALX
Price
$26.85
Change
+$0.09 (+0.34%)
Updated
Oct 17 closing price
Net Assets
164.92M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

CMALX vs RLBCX

Header iconCMALX vs RLBCX Comparison
Open Charts CMALX vs RLBCXBanner chart's image
Crawford Multi-Asset Income
Price$26.85
Change+$0.09 (+0.34%)
VolumeN/A
Net Assets164.92M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
CMALX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
CMALX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMALX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. CMALX (165M). CMALX pays higher dividends than RLBCX: CMALX (4.03) vs RLBCX (1.49). CMALX was incepted earlier than RLBCX: CMALX (8 years) vs RLBCX (23 years). CMALX (1.24) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. CMALX (19.00). RLBCX has a lower initial minimum investment than CMALX: RLBCX (250) vs CMALX (10000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. CMALX (1.50). CMALX return over 5 years is better than : 52.92 vs. RLBCX (40.24).
CMALXRLBCXCMALX / RLBCX
Total Expense Ratio0.990.89111%
Annual Report Gross Expense Ratio1.240.89139%
Fund Existence8 years23 years-
Gain YTD4.78814.36433%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets165M265B0%
Annual Yield % from dividends4.031.49271%
Returns for 1 year1.508.3418%
Returns for 3 years31.1049.2663%
Returns for 5 years52.9240.24132%
Returns for 10 yearsN/A72.18-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals